Cargando…

Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa

BACKGROUND: Brief messaging interventions, including Short Message Service (SMS) text-messages, delivered via mobile device platforms, show promise to support and improve treatment adherence. To understand how these interventions work, and to facilitate transparency, we need clear descriptions of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Leon, Natalie, Namadingo, Hazel, Bobrow, Kirsty, Cooper, Sara, Crampin, Amelia, Pauly, Bruno, Levitt, Naomi, Farmer, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811237/
https://www.ncbi.nlm.nih.gov/pubmed/33451308
http://dx.doi.org/10.1186/s12889-020-10089-6
_version_ 1783637457513742336
author Leon, Natalie
Namadingo, Hazel
Bobrow, Kirsty
Cooper, Sara
Crampin, Amelia
Pauly, Bruno
Levitt, Naomi
Farmer, Andrew
author_facet Leon, Natalie
Namadingo, Hazel
Bobrow, Kirsty
Cooper, Sara
Crampin, Amelia
Pauly, Bruno
Levitt, Naomi
Farmer, Andrew
author_sort Leon, Natalie
collection PubMed
description BACKGROUND: Brief messaging interventions, including Short Message Service (SMS) text-messages, delivered via mobile device platforms, show promise to support and improve treatment adherence. To understand how these interventions work, and to facilitate transparency, we need clear descriptions of the intervention development process. METHOD: We describe and reflect on the process of designing and pretesting an evidence- and theory-informed brief messaging intervention, to improve diabetes treatment adherence in sub-Saharan Africa. We followed the stepwise approach recommended by the Medical Research Council, United Kingdom (MRC UK) Framework for Development and Evaluation of Complex Health Interventions and guidance for mobile health intervention development. RESULTS: We used a four-phase, iterative approach that first generated primary and secondary evidence on the lived experience of diabetes, diabetes treatment services and mobile-phone use. Second, we designed a type 2 diabetes-specific, brief text-message library, building on our previous hypertension text-message library, as well as drawing on the primary and secondary data from phase one, and on expert opinion. We then mapped the brief text-messages onto behaviour change (COM-B) theoretical constructs. Third, we refined and finalised the newly developed brief text-message library through stakeholder consultation and translated it into three local languages. Finally, we piloted the intervention by pre-testing the automated delivery of the brief text-messages in the trial sites in Malawi and South Africa. The final SMS text Adherence suppoRt for people with type 2 diabetes (StAR2D) intervention was tested in a randomised controlled trial in Malawi and South Africa (trial registration: ISRCTN70768808). CONCLUSION: The complexity of public health interventions requires that we give more attention to intervention development work. Our documentation and reflection on the StAR2D intervention development process promotes transparency, replicability, assessment of intervention quality, and comparison with other studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-10089-6.
format Online
Article
Text
id pubmed-7811237
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78112372021-01-18 Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa Leon, Natalie Namadingo, Hazel Bobrow, Kirsty Cooper, Sara Crampin, Amelia Pauly, Bruno Levitt, Naomi Farmer, Andrew BMC Public Health Research Article BACKGROUND: Brief messaging interventions, including Short Message Service (SMS) text-messages, delivered via mobile device platforms, show promise to support and improve treatment adherence. To understand how these interventions work, and to facilitate transparency, we need clear descriptions of the intervention development process. METHOD: We describe and reflect on the process of designing and pretesting an evidence- and theory-informed brief messaging intervention, to improve diabetes treatment adherence in sub-Saharan Africa. We followed the stepwise approach recommended by the Medical Research Council, United Kingdom (MRC UK) Framework for Development and Evaluation of Complex Health Interventions and guidance for mobile health intervention development. RESULTS: We used a four-phase, iterative approach that first generated primary and secondary evidence on the lived experience of diabetes, diabetes treatment services and mobile-phone use. Second, we designed a type 2 diabetes-specific, brief text-message library, building on our previous hypertension text-message library, as well as drawing on the primary and secondary data from phase one, and on expert opinion. We then mapped the brief text-messages onto behaviour change (COM-B) theoretical constructs. Third, we refined and finalised the newly developed brief text-message library through stakeholder consultation and translated it into three local languages. Finally, we piloted the intervention by pre-testing the automated delivery of the brief text-messages in the trial sites in Malawi and South Africa. The final SMS text Adherence suppoRt for people with type 2 diabetes (StAR2D) intervention was tested in a randomised controlled trial in Malawi and South Africa (trial registration: ISRCTN70768808). CONCLUSION: The complexity of public health interventions requires that we give more attention to intervention development work. Our documentation and reflection on the StAR2D intervention development process promotes transparency, replicability, assessment of intervention quality, and comparison with other studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-10089-6. BioMed Central 2021-01-15 /pmc/articles/PMC7811237/ /pubmed/33451308 http://dx.doi.org/10.1186/s12889-020-10089-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Leon, Natalie
Namadingo, Hazel
Bobrow, Kirsty
Cooper, Sara
Crampin, Amelia
Pauly, Bruno
Levitt, Naomi
Farmer, Andrew
Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa
title Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa
title_full Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa
title_fullStr Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa
title_full_unstemmed Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa
title_short Intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-Saharan Africa
title_sort intervention development of a brief messaging intervention for a randomised controlled trial to improve diabetes treatment adherence in sub-saharan africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811237/
https://www.ncbi.nlm.nih.gov/pubmed/33451308
http://dx.doi.org/10.1186/s12889-020-10089-6
work_keys_str_mv AT leonnatalie interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica
AT namadingohazel interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica
AT bobrowkirsty interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica
AT coopersara interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica
AT crampinamelia interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica
AT paulybruno interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica
AT levittnaomi interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica
AT farmerandrew interventiondevelopmentofabriefmessaginginterventionforarandomisedcontrolledtrialtoimprovediabetestreatmentadherenceinsubsaharanafrica